Regeneron makes $250M bid to buy pharmaceuticals firm

Published on 20 Apr 2022 on Albany Times Union

Regeneron Pharmaceuticals Inc. is moving to acquire Checkmate Pharmaceuticals in a $250 million...

Read the rest of the article

Start tracking your investments with Statfolio

The Federal Circuit recently issued decisions in a pair of appeals that provide guidance about wh...

The National Law Review 19 Feb 2025

, opens new tab has won a court ruling that will make it harder for U.S. authorities to win a...

Reuters 19 Feb 2025

While Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shareholders are probably generally happy, th...

Simply Wall St. · via Yahoo Finance 13 Feb 2025

We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In...

Insider Monkey · via Yahoo Finance 2 Feb 2025

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-ye...

Zacks · via Yahoo Finance 31 Jan 2025

Investors in Regeneron Pharmaceuticals, Inc. REGN need to pay close attention to the stock based ...

Zacks · via Yahoo Finance 28 Jan 2025

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we ar...

Insider Monkey · via Yahoo Finance 28 Jan 2025

We recently published a list of 10 Best Stocks to Buy and Hold For 2025. In this article, we are...

Insider Monkey · via Yahoo Finance 27 Jan 2025

We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, w...

Insider Monkey · via Yahoo Finance 24 Jan 2025

We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going ...

Insider Monkey · via Yahoo Finance 19 Jan 2025